Showing 1,081 - 1,100 results of 27,284 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (we decrease)) ))', query time: 0.98s Refine Results
  1. 1081

    Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

    Published 2025
    “…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
  2. 1082

    Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

    Published 2025
    “…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
  3. 1083

    Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

    Published 2025
    “…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
  4. 1084

    Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

    Published 2025
    “…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu<sub>50</sub>Zr<sub>50</sub> layers. …”
  5. 1085

    S1 File - by Michael Gulledge (20577135)

    Published 2025
    “…During withdrawal, there was a profound loss (peaking on days 2–3) and gradual return of diurnal structure in sleep, body temperature, and locomotor activity, as well as decreased sleep and wake bout durations dependent on lights on/off. …”
  6. 1086
  7. 1087
  8. 1088
  9. 1089
  10. 1090
  11. 1091
  12. 1092
  13. 1093

    The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance <i>In Vitro</i> and <i>In Vivo</i> Derived from Human Breast MCF-7/ADR Cells by Long Wu (655081)

    Published 2014
    “…Multidrug resistance reversal by 3-Bromopyruvate occurred through at least three approaches, namely, a decrease in the intracellular level of ATP and HK-II bioactivity, the inhibition of ATPase activity, and the slight decrease in P-glycoprotein expression in MCF-7/ADR cells.…”
  14. 1094
  15. 1095
  16. 1096
  17. 1097
  18. 1098

    Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

    Published 2023
    “…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
  19. 1099

    Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

    Published 2023
    “…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”
  20. 1100

    Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

    Published 2023
    “…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”